YD Bio Limited Warrants (YDESW) Revenue History
Annual and quarterly revenue from 2023 to present
YDESW Revenue Over Time (2023–2024)
YDESW Revenue Growth History
1 of 1 years with positive growth- FY2023 revenue growth
- N/A
- FY2024 revenue growth
- +45.8%
YDESW Revenue Analysis (2023–2024)
Current Revenue & Growth
As of July 8, 2026, YD Bio Limited Warrants (YDESW) generated trailing twelve-month (TTM) revenue of $0.
Historical Growth Trajectory
YDESW's historical revenue data shows various trends over time. YD Bio Limited Warrants's highest annual revenue of $510,360 was recorded in 2024, an all-time high.
Peer Comparison
Compared to Healthcare sector peers — including BNTX (+1.9% YoY), NVAX (-52.5% YoY), and OCGN (-1.3% YoY). Compare YDESW vs BNTX →
YDESW Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| YDESWCurrent | $0 | - | - | -286.5% | |
 BNTX | $2.8B | +1.9% | +41.7% | -22.6% | |
 NVAX | $1.1B | -52.5% | +118.8% | 50.1% | |
 OCGN | $4M | -1.3% | +152.5% | -1425.7% | |
 VXRT | $237M | +439.3% | +125.8% | 7.6% | |
 INO | $65,343 | -100.0% | -61.2% | -132871.3% |
YDESW Historical Revenue Data (2023–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $510K | +45.8% | $155K | 30.4% | $-1,461,930 | -286.5% |
| 2023 | $350K | - | $153K | 43.8% | $-9,847 | -2.8% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
3+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
YDESW — Frequently Asked Questions
Quick answers to the most common questions about buying YDESW stock.
Is YDESW's revenue growth accelerating or slowing?
YDESW TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is YDESW's revenue history from 2023 to 2026?
YD Bio Limited Warrants (YDESW) revenue history spans 2023 to 2026. TTM revenue as of 2026 is $0.00, growing at N/A YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is YDESW's long-term revenue growth rate (CAGR)?
YD Bio Limited Warrants's 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of N/A is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for YDESW.
Why does YDESW's quarterly revenue fluctuate?
YDESW quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. YD Bio Limited Warrants's revenue data from 2023 to 2026 shows full historical quarterly detail on this page.
How is YDESW's revenue distributed by segment?
YDESW reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does YDESW's revenue compare to industry peers?
YD Bio Limited Warrants (YDESW) with TTM revenue of $0.00 and N/A YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.